Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi.
about
Estimating the capacity for ART provision in Tanzania with the use of data on staff productivity and patient lossesAdherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitatorsExplaining adherence success in sub-Saharan Africa: an ethnographic studyCost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisalHIV drug resistance early warning indicators in Namibia for public health actionOverview of microbicides for the prevention of human immunodeficiency virus.Patient-reported barriers and facilitators to antiretroviral adherence in sub-Saharan Africa.Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review.Unplanned antiretroviral treatment interruptions in southern Africa: how should we be managing these?Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda.Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators.Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators.Changing clinical needs of people living with AIDS and receiving home based care in Malawi--the Bangwe Home Based Care Project 2003-2008--a descriptive studyHIV/AIDS, undernutrition, and food insecurityLong-term adherence to antiretroviral treatment and program drop-out in a high-risk urban setting in sub-Saharan Africa: a prospective cohort studyRetention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approachThe need for double-sampling designs in survival studies: an application to monitor PEPFARImplementation of a validated peripheral neuropathy screening tool in patients receiving antiretroviral therapy in Mombasa, KenyaPopulation-based monitoring of HIV drug resistance in Namibia with early warning indicators.Determinants of retention in care in an antiretroviral therapy (ART) program in urban Cameroon, 2003-2005.Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in NigeriaFree HIV antiretroviral therapy enhances adherence among individuals on stable treatment: implications for potential shortfalls in free antiretroviral therapy.Social and cultural efficacies of medicines: complications for antiretroviral therapy.Sex differences in the incidence of peripheral neuropathy among Kenyans initiating antiretroviral therapyNeuropsychiatric and socioeconomic status impact antiretroviral adherence and mortality in rural ZambiaThe impact of herbal drug use on adverse drug reaction profiles of patients on antiretroviral therapy in zimbabweEpidemiology of HIV/AIDS in adults in MalawiA causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in AfricaDevelopment, Validation, and Field-Testing of an Instrument for Clinical Assessment of HIV-Associated Neuropathy and Neuropathic Pain in Resource-Restricted and Large Population Study SettingsPlasma nevirapine concentrations predict virological and adherence failure in Kenyan HIV-1 infected patients with extensive antiretroviral treatment exposureAdverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study.Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic reviewInformation systems for patient follow-up and chronic management of HIV and tuberculosis: a life-saving technology in resource-poor areasCurrent strategies for improving access and adherence to antiretroviral therapies in resource-limited settings.Patient costs associated with accessing HIV/AIDS care in MalawiUnderstanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach.Effects of a reduced dose of stavudine on the incidence and severity of peripheral neuropathy in HIV-infected adults in South AfricaAdverse effects of highly active antiretroviral therapy in developing countries.Adverse drug reactions to antiretroviral therapy: Results from spontaneous reporting system in NigeriaSecond-line antiretroviral therapy: long-term outcomes in South Africa.
P2860
Q21143796-B9C21EB4-2E55-4879-BA15-91085070CAACQ28469073-4B070DF4-8A79-461B-BC5B-F59C0568E46FQ28474661-BD5CE24E-34BC-4516-B07D-F0B1ED2C2333Q28476337-0B2EA2BD-4148-4F67-BD71-5DCA56A0A948Q28533732-2D3483C4-A676-4E80-B141-CA56CAB73EB8Q30413777-7A1161E6-C505-41B7-A549-4580AA464C8DQ30843756-75558B2C-9584-48EE-AA29-28822AFE2212Q33282786-95921CC5-AAE9-455C-B990-84123AA66CB3Q33390354-B9E59BDF-55E1-4FE3-82AD-2F59550D5CF5Q33459535-E2248A24-4D01-4928-B9CC-9E2097E54FC1Q33532758-7FB3DEC4-02B6-4DA3-8AB4-4DAD7974D523Q33532759-D792A567-FF4E-4806-98CD-B108B37D2E7CQ33615378-89F7D589-0427-4536-9259-8DDF4ECCBED1Q33701378-BACBAB4B-207A-4CFD-B848-0EE9F99456D2Q33737751-655E08BD-F795-455A-9837-75B4B738AB5BQ33982933-4E2578F7-1002-4C7F-AD91-62B0DBD795C0Q34065148-C7AC438F-7ACD-405D-BD48-CEEF3A443DF2Q34087372-9057539B-9A08-4F83-B2FF-CC235571FFEBQ34283361-9435C01E-B3C3-484B-B423-CB2E2FA98E7EQ34320918-1D55983A-0230-4BAC-AA53-81BBA8D58268Q34604679-1DC2599B-0D58-411F-8C33-4A065103C5D2Q34988153-B846D3A5-36CA-4000-864A-32A3FB157DB2Q35131010-B45D30C7-5DDB-4D29-8CF3-BED36BCC6796Q35164547-65E9AF63-62EE-4518-8C3F-A1F5EC3D97B5Q35246212-E8819D57-CA40-4C1D-AFD8-65608B85EF94Q35855545-694E016D-FA83-4875-8673-7FDEA6ADA5BFQ35938001-A82288BC-E02E-49B4-8E17-1CD571056636Q35963111-F0496431-2EB5-4C9F-9160-1DB3FEA953F8Q36169291-2698725D-8C7B-46B3-B819-586A439067A4Q36290009-31D01C38-74A6-4968-BC49-2D8539304087Q36325668-7896FDCB-5DF6-4D3D-82CD-550F1D4D106AQ36394557-96967476-7BC6-4199-A8EE-ED5442576AE0Q36420781-EE95EE44-9E83-4E71-8161-C9DA637AFBCFQ36530478-25D688DB-87BA-45CB-82F0-F1E8F99E1274Q36704878-F7E23217-B1B5-4681-9548-5B24AAA2021CQ36712377-C4A20CBD-58D6-4E15-AF59-3A9B0CAEAF81Q36870758-04922C28-21B9-47D9-B4E0-90451D279546Q36945761-82A9B9FB-A957-4797-9113-7D3FF3D763DEQ36979014-4CED2F3C-4D56-4F84-9AFA-7A348970B434Q37158277-BBA0A88A-F930-4851-AB07-6AD9D6FAEAFE
P2860
Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Evaluation of antiretroviral t ...... r setting in Blantyre, Malawi.
@en
Evaluation of antiretroviral t ...... r setting in Blantyre, Malawi.
@nl
type
label
Evaluation of antiretroviral t ...... r setting in Blantyre, Malawi.
@en
Evaluation of antiretroviral t ...... r setting in Blantyre, Malawi.
@nl
prefLabel
Evaluation of antiretroviral t ...... r setting in Blantyre, Malawi.
@en
Evaluation of antiretroviral t ...... r setting in Blantyre, Malawi.
@nl
P2093
P2860
P1476
Evaluation of antiretroviral t ...... or setting in Blantyre, Malawi
@en
P2093
Cooper Nyirenda
David M Burger
Eduard E Zijlstra
Jane Mallewa
Joep J van Oosterhout
Johnstone J Kumwenda
Michel P de Baar
Neena Bodasing
Rob Schuurman
P2860
P304
P356
10.1111/J.1365-3156.2005.01409.X
P50
P577
2005-05-01T00:00:00Z